Man Group
DRNA

Man Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Man Group’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30,254
Closed -$1.13M – 2187
2021
Q2 		$1.13M Sell
30,254
-253,905
-89% -$7.78M ﹤0.01% 1366
2021
Q1 		$7.27M Buy
284,159
+161,386
+131% +$4.12M 0.03% 543
2020
Q4 		$2.71M Buy
122,773
+12,273
+11% +$270K 0.01% 1083
2020
Q3 		$1.99M Buy
110,500
+33,358
+43% +$691K 0.01% 1196
2020
Q2 		$1.96M Sell
77,142
-2,330
-3% -$50.2K 0.01% 1076
2020
Q1 		$1.46M Buy
+79,472
New +$1.54M 0.01% 1001
2019
Q1 		– Sell
-48,138
Closed -$515K – 2117
2018
Q4 		$515K Buy
+48,138
New +$633K ﹤0.01% 1621

Other funds holding DRNA

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Man Group's DRNA Position: Q3 2021 in Review

Man Group sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q3 2021, closing a stake of 30,254 shares — an estimated $1.13M sold.

Man Group first reported a position in DRNA in Q4 2018 and held it in 7 quarters. The position peaked at $7.27M in Q1 2021. 173 funds tracked by Wall St. Rank hold DRNA as of Q3 2021.

  • Man Group reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Man Group sold 30,254 Dicerna Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.13M.
  • Man Group first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2018 and held it in 7 quarters.
  • Man Group's Dicerna Pharmaceuticals, Inc. position peaked at $7.27M in Q1 2021.
  • 173 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q3 2021.

Based on Man Group's 13F filing for Q3 2021, filed 15 Nov 2021.